Table of Contents Table of Contents
Previous Page  46 / 172 Next Page
Information
Show Menu
Previous Page 46 / 172 Next Page
Page Background

Abstracts of the 22

nd

National Congress of Digestive Diseases / Digestive and Liver Disease 48S2 (2016) e67–e231

e107

orifice. Once the waist disappeared, the balloon remained inflated

for 60 s.

Results:

A total of 29 patients with CBD large stones were evaluated:

11 male (38%)/ 18 female (62%) with a mean age of 71.9±14.7.

Technical success (complete dilation) was reached in all patients

(100%) with a median final dilation of 15 mm in diameter: 10 mm in

4 patients (14%), 15 mm in 12 patients (41%), 18 mm in 11 patients

(38%), 20 mm in 2 patients (7%). In 6 patients (21%) EST was done

before the current procedure and DASE was performed due to stones

recurrence. In all patients but two (93%) large stones were successful

removed from the CBD (19 with retrieval balloon and 8 with aid of

mechanical lithotripsy). In those with DASE failure: 1 was treated

with intra-coledocical laser lithotripsy and 1 with surgical approach.

Only 2 early complications were recorded (7%): both mild bleeding

resolved after endoclips placement. In one patient CBD stones

recurred after 2 months.

Conclusions:

DASE after EST is an alternative, effective and safe

method for removal of CBD large stones.

OC.10.2

QUALITY EVALUATION AND PROFESSIONAL ACCREDITATION

IN DIGESTIVE ENDOSCOPY. PRELIMINARY DATA ACQUIRED

THROUGH PEER-REVIEWED SITE VISITS

Fasoli R.*

1

, Spinzi G.

2

, Torresan F.

3

, Labardi M.

4

, Merighi A.

5

,

Milano A.

6

, Riccardi L.

7

, Iannone T.

8

, Capelli M.

9

1

ASL 1 Liguria, Imperia, Italy,

2

Ospedale Valduce, Como, Italy,

3

Azienda

Ospedaliera Sant’Orsola Malpighi, Bologna, Italy,

4

Ospedale Nuovo del

Mugello, Firenze, Italy,

5

Policlinico di Modena, Modena, Italy,

6

ASL 2

Abruzzo, Chieti, Italy,

7

ASL 1 Umbria, Terni, Italy,

8

ASP Reggio Calabria,

Polistena, Italy,

9

Kiwa Cermet, Bologna, Italy

Background and aim:

Although guidelines on quality parameters

in digestive endoscopy have been implemented and widely shared,

in our country scanty data exist on their evaluation by an external

party and the efficacy of corrective interventions after a first report.

Material and methods:

With the support of Kiwa Cermet Italia

Certification Company, SIED has recently endorsed a nationwide

program of professional accreditation of endoscopy services. Based

on a handbook including a checklist to score quality items prepared

by Sied Quality Team, an array of site visits has been set up.

The first part of the project implies a first visit to spotlight

inappropriate or critical issues followed by a second visit to verify

the outcome of suggested corrective measures.

Adhesion to the protocol has been on a voluntary basis by the

involved department.

The team included: a leader (CM) dedicated to the evaluation

of general organization, two gastroenterologists (one for upper

GI evaluation, the other one for lower GI evaluation) and a nurse

dedicated to the observation of nursing and reprocessing procedures.

Results:

So far, 4 centres have been visited; in three a follow-up visit

has already been carried out, with a time lag of about 9 months.

During the first visit, the most represented critical issues were:

-Upper GI: Forrest, Los Angeles and Prague classifications; gastric

biopsies protocols.

-Lower GI: post-polypectomy surveillance; colo-rectal biopsy

protocols in inflammatory bowel diseases and chronic diarrhoea.

-Nursing management/reprocessing: pre and post procedure

registration of vital signs; Gloucester scale of post-procedure

discomfort; traceability and periodic reports on disinfection

procedures; management of histopathological reports.

Items quoted as critical/inadequate at the first visit have been

efficaciously managed in two centres, which gained professional

accreditation.

The third centre has efficaciously corrected remarks regarding

reprocessing, thanks to relevant technological improvements, but

has failed to correct most of other remarks; for these reasons, it has

not achieved accreditation.

Conclusions:

These data give a preliminary outlook concerning

most frequent critical issues in Endoscopy services. Follow-up visits

obtained satisfactory results and led to professional accreditation

in two out of three centres. These results are in part secondary to a

promising cooperation between professionals and health managers.

We look forward having more detailed data once a higher number of

site visits will be carried out.

OC.10.3

MID TERM RESULTS OF SECOND POEM FOR RECURRENT

ACHALASIA: DATA FROM A LARGE COHORT OF PATIENTS

Balassone V.*, Ikeda H., Inoue H.

Digestive Diseases Centre, Showa University Koto-Toyosu Hospital,

Tokyo, Japan

Background and aim:

Peroral Endoscopic Myotomy (POEM) is

an emerging non-incisional treatment for achalasia and for other

esophageal peristalsis disorders. Despite its efficacy is widely

reported as high (% of patients with Eckardt score ≤ 3 after POEM

ranges between 91.7-100), recurrent symptoms are reported.

Because of the relative novelty of this technique and its high efficacy,

long-term follow up results with an adequate number of patients

underwent a second POEM are still missing.

Material and methods:

We retrospectively reviewed our database

of all patients underwent a second POEM. Patient and achalasia

characteristics, peri- and post-operative data (including high-

resolution manometry, barium swallow and clinical assessment

before 1st POEM, 2nd POEM and during follow up) were therefore

collected and analyzed. Outcome measures were incidence of intra-

and post-operative adverse events for safety issues and % of patients

with Eckardt score < 3 after second POEM for efficacy.

Results:

Between August 2010 and October 2015, 27 patients under­

went a second POEM for recurrent symptoms. Patient and achalasia

Table 1

Baseline characteristics of patients who underwent second POEM

Demographics

N. of patients

27

Age, median (range), y

45,8 (21-77)

Male, n. (%)

15 (55.6)

BMI, mean (range)

21,2 (14,7-37,2)

Achalasia characteristics

Duration of symptoms, mean (range), y

9,5 (0,5-32)

Type of Achalasia

, n (%)

I

6 (22,2)

II

6 (22,2)

III

0

Not available

15 (55,6)

Manometry IRP, mean (range), mmHg

23,4 (8-48)

Availability of IRP %

48%

Previous treatments, n (%)

Pneumatic balloon dilation

14 (51,9)

None

12 (44,4)

Heller Myotomy

1 (3,7)

Esophageal dilation

None

0

Mild

7 (25,9)

Moderate

19 (70,4)

Severe

1 (3,7)

Eckardt Score, mean (range)

6,6 (2-10)

According to Chicago Classification v. 3.0